↓ Skip to main content

Dove Medical Press

Empagliflozin in the treatment of type 2 diabetes: evidence to date

Overview of attention for article published in Drug Design, Development and Therapy, October 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent
1 patent
wikipedia
7 Wikipedia pages

Readers on

mendeley
122 Mendeley
Title
Empagliflozin in the treatment of type 2 diabetes: evidence to date
Published in
Drug Design, Development and Therapy, October 2015
DOI 10.2147/dddt.s69926
Pubmed ID
Authors

Jay H Shubrook, Babak Baradar Bokaie, Sarah E Adkins

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Ireland 1 <1%
Unknown 120 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 11%
Student > Master 13 11%
Researcher 10 8%
Student > Bachelor 9 7%
Other 7 6%
Other 20 16%
Unknown 50 41%
Readers by discipline Count As %
Medicine and Dentistry 32 26%
Pharmacology, Toxicology and Pharmaceutical Science 12 10%
Chemistry 7 6%
Nursing and Health Professions 6 5%
Agricultural and Biological Sciences 3 2%
Other 10 8%
Unknown 52 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#5,503,217
of 25,576,275 outputs
Outputs from Drug Design, Development and Therapy
#378
of 2,274 outputs
Outputs of similar age
#66,210
of 287,373 outputs
Outputs of similar age from Drug Design, Development and Therapy
#15
of 110 outputs
Altmetric has tracked 25,576,275 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,274 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,373 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.